CVE:SBM Sirona Biochem (SBM) Stock Price, News & Analysis C$0.06 -0.01 (-7.69%) As of 03/7/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About Sirona Biochem Stock (CVE:SBM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Sirona Biochem alerts:Sign Up Key Stats Today's RangeC$0.06▼C$0.0650-Day RangeC$0.06▼C$0.0652-Week RangeC$0.02▼C$0.10Volume182,010 shsAverage Volume79,592 shsMarket CapitalizationC$15.41 millionP/E RatioN/ADividend Yield1.50%Price TargetN/AConsensus RatingN/A Company Overview Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada. Read More Receive SBM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sirona Biochem and its competitors with MarketBeat's FREE daily newsletter. Email Address SBM Stock News HeadlinesSirona Biochem Corp. (SBM.V) - Yahoo FinanceJune 28, 2025 | au.finance.yahoo.comSirona Biochem Launches Convertible Debenture Offering to Raise $400,000April 22, 2025 | tipranks.comBanks aren’t ready for this altcoin—are you?In crypto, timing is everything. By the time the masses catch wind of this, the biggest gains could be ancient history. Are you ready to potentially change your financial future forever?July 2 at 2:00 AM | Crypto 101 Media (Ad)Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbHApril 22, 2025 | financialpost.comFSirona Biochem Showcases TFC-1326 in Stonegate Healthcare’s Landmark ReportJanuary 16, 2025 | markets.businessinsider.comUpdate: Stonegate Initiates Coverage on Sirona Biochem Corp (TSX-V:SBM)October 22, 2024 | theglobeandmail.comSirona Biochem Corp (SBM)October 2, 2024 | investing.comSirona Biochem Corp. With CEO & Chairman, Howard Verrico | September 26, 2024September 27, 2024 | msn.comSee More Headlines SBM Stock Analysis - Frequently Asked Questions How have SBM shares performed this year? Sirona Biochem's stock was trading at C$0.06 at the beginning of 2025. Since then, SBM stock has increased by 0.0% and is now trading at C$0.06. View the best growth stocks for 2025 here. How do I buy shares of Sirona Biochem? Shares of SBM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Sirona Biochem own? Based on aggregate information from My MarketBeat watchlists, some other companies that Sirona Biochem investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Apellis Pharmaceuticals (APLS), Athersys (ATHX), Iovance Biotherapeutics (IOVA), Neovasc (NVCN) and Sorrento Therapeutics (SRNE). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:SBM CIKN/A Webwww.sironabiochem.com Phone604-641-4466FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$2.67 million Net MarginsN/A Pretax MarginN/A Return on Equity-9,810.47% Return on Assets-148.11% Debt Debt-to-Equity Ratio219.21 Current Ratio0.34 Quick Ratio2.41 Sales & Book Value Annual SalesC$683.77 thousand Price / Sales22.54 Cash FlowC$0.00 per share Price / Cash Flow35.00 Book ValueC($0.01) per share Price / Book-6.00Miscellaneous Outstanding Shares256,820,000Free FloatN/AMarket CapC$15.41 million OptionableNot Optionable Beta-0.03 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (CVE:SBM) was last updated on 7/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sirona Biochem Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sirona Biochem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.